Variant report
Variant | nsv970777 |
---|---|
Chromosome Location | chr7:146358313-146369940 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs556858414 | chr7:146358321-146358322 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs575129740 | chr7:146358337-146358338 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs544226012 | chr7:146358339-146358340 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs574266609 | chr7:146358377-146358378 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs560636363 | chr7:146358406-146358407 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs536757938 | chr7:146358462-146358463 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs574164037 | chr7:146358467-146358468 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs189404690 | chr7:146358491-146358492 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs1494456 | chr7:146358510-146358511 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs532373708 | chr7:146358512-146358513 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs180993332 | chr7:146358543-146358544 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs187381684 | chr7:146358545-146358546 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs377186734 | chr7:146358558-146358559 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs369676485 | chr7:146358657-146358658 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs80328232 | chr7:146358670-146358671 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs71165024 | chr7:146358671-146358672 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs71956015 | chr7:146358672-146358673 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs200473775 | chr7:146358674-146358675 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs531591605 | chr7:146358687-146358688 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs35165250 | chr7:146358710-146358711 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs557200528 | chr7:146358736-146358737 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs34652048 | chr7:146358824-146358825 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs386411580 | chr7:146358825-146358826 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs548566765 | chr7:146358826-146358827 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs58432583 | chr7:146358854-146358855 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs568488964 | chr7:146358858-146358859 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs527739173 | chr7:146358861-146358862 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs139835118 | chr7:146358866-146358867 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs570948160 | chr7:146358883-146358884 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs540072456 | chr7:146358885-146358886 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs556559754 | chr7:146358895-146358896 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs570363001 | chr7:146358925-146358926 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs535764467 | chr7:146358952-146358953 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs554118619 | chr7:146358971-146358972 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs114948715 | chr7:146358993-146358994 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs539928494 | chr7:146358997-146358998 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs368693201 | chr7:146358998-146358999 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs144104576 | chr7:146359017-146359018 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs576938327 | chr7:146359021-146359022 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs374529828 | chr7:146359041-146359042 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs562801114 | chr7:146359089-146359090 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs546012198 | chr7:146359090-146359091 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs7797256 | chr7:146359100-146359101 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs192108384 | chr7:146359115-146359116 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs183374309 | chr7:146359137-146359138 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs114275669 | chr7:146359152-146359153 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs527349972 | chr7:146359253-146359254 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs386719014 | chr7:146359271-146359272 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs2533088 | chr7:146359273-146359274 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs185977850 | chr7:146359292-146359293 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Wilms tumour | 21544195 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
abnormal development | 18461090 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Breast cancer | 16272173 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Stuttering | 21108403 | CNVD |
Breast cancer | 17603634 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Myelodysplastic syndrome | 17634407 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 17133270 | CNVD |
Schizophrenia | 17646849 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Heart disease | 21282601 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Pancreatitis | 21956041 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Gastric cancer | 16891809 | CNVD |
Lung cancer | 17086460 | CNVD |
Autism | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Tourette syndrome | 19546859 | CNVD |
Cancer | 20164920 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Autism | 20808228 | CNVD |
Schizophrenia | 20838587 | CNVD |
Schizophrenia | 20718829 | CNVD |
Neuropsychiatric disorder | 21827697 | CNVD |
Melanoma | 20877625 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21509527 | CNVD |
Autism | 20964600 | CNVD |
Epilepsy | 17646849 | CNVD |
Mental retardation | 19896112 | CNVD |
Epilepsy | 20502679 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:146355000-146358400 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
2 | chr7:146357800-146358600 | Enhancers | Fetal Lung | lung |
3 | chr7:146357800-146359400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
4 | chr7:146358000-146358600 | Enhancers | Fetal Brain Male | brain |
5 | chr7:146358000-146358800 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
6 | chr7:146358200-146359600 | Enhancers | Primary hematopoietic stem cells | blood |
7 | chr7:146358400-146358600 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
8 | chr7:146358800-146359400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |